Topic Paragraphs
FDA Accomplishments for the American People
FDA Seizes 7-OH Opioids to Protect American Consumers
The U.S. Food and Drug Administration, in coordination with the U.S. Department of Justice, announced today that the U.S. Marshals Service seized approximately 73,000 units of 7-hydroxymitragynine (7-OH) products—valued at roughly $1 million—from three firms in Missouri.
Read MoreRecent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
Alerting you to the latest recalls of potentially unsafe FDA-regulated products gathered from press releases and other public notices. Not all recalls have press releases or are posted on this website.
Dec 26
Gold Star Distribution Inc., Issues Recall of Certain FDA-Regulated Products in Three States Including Drugs, Devices, Cosmetics, Human Foods, and Pet Foods
Animal & Veterinary, Cosmetics, Dietary Supplements, Drugs, Food & Beverages, Medical Devices
Dec 24
Consumers Supply Distributing, LLC Recalls Country Vet Biscuits for Dogs Due to Possible Salmonella Health Risk
Animal & Veterinary, Food & Beverages
Dec 23
Gregory’s Foods Issues Allergy Alert on Undeclared Peanuts in "Bag Full of Cookies" White Chocolate Macadamia Nut Frozen Cookie Dough
Food & Beverages
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
FDA Encourages Development of New, Reliable Alternatives to Animal Testing in Sunscreen
FDA strongly encourages companies to continue to develop new, reliable ways to minimize animal testing.
FDA Focuses on Closing the Clinical Trial Reporting Gap for Research Integrity
The FDA is committed to ensuring data transparency by promoting timely registration and reporting of results information to ClinicalTrials.gov.
FDA Advances Drug Development Innovation by Establishing ISTAND as Permanent Qualification Program
ISTAND supports innovative, science-driven approaches that improve drug development and regulatory decision-making.
Recently Published Guidances
Dec 22
Formal Dispute Resolution and Administrative Hearings of Final Administrative Orders Under Section 505G of the Federal Food, Drug, and Cosmetic Act
Drugs
Dec 19
Processes and Practices Applicable to Bioresearch Monitoring Inspections
Animal & Veterinary, Biologics, Dietary Supplements, Drugs, Food & Beverages, Medical Devices, Radiation-Emitting Products, Tobacco
Dec 18
Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices
Biologics, Medical Devices, Radiation-Emitting Products